Literature DB >> 164306

Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia.

M Cucuianu, T A Popescu, A Opincaru, S Hărăgus.   

Abstract

Starting from previous observations emphasizing an increased pseudocholinesterase (PCE) activity in obese and hyperlipemic subjects, the behaviour of this enzyme and of ceruloplasmin was studied in connection with changes of serum lipids and lipoproteins in various types of hyperlipoproteinemia. When compared to values detected in 67 middle-aged normal weight normolipemic subjects, PCE activity was found to be significantly greater (smaller than 0.001) in the 49 overweight subjects without obvious hyperlipemia but presenting a moderate increase of the prebeta electrophoretic fraction. PCE activity was much higher in lean or overweight subjects with endogenous hypertriglyceridemia (68 patients with type IV and 86 patients with mixed hyperlipemia). The slight increase of mean values of PCE activity in the 53 subjects with type II-a was due mainly to overweight subjects, while this enzyme's activity was not significantly changed in lean subjects with pure hypercholesterolemia. PCE activity was positively correlated with serum triglyceride (r equals 0.540; p smaller than 0.001) and the prebeta electrophoretic fraction (r equals 610; p smaller than 0.001). The correlation with beta-lipoproteins was not significant. Ceruloplasmin levels were not significantly changed. It is suggested that elevation of PCE activity could be connected to mechanisms leading to an increased secretion rate of lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164306     DOI: 10.1016/0009-8981(75)90213-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Effect of dichlorvos on the activity of lipoprotein lipase from adipose tissue, on plasma lipids and postheparin lipolytic plasma activity in rats.

Authors:  A Kozlowska; B Sadurska; T Szymczyk
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

2.  Serum zinc and copper in hyperlipoproteinemia.

Authors:  G Uza; S Gabor; A Kovats; R Vlaicu; M Cucuianu
Journal:  Biol Trace Elem Res       Date:  1985-11       Impact factor: 3.738

3.  Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats.

Authors:  V Annapurna; I Senciall; A J Davis; K M Kutty
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

4.  Altered brain cholinergic enzymes activity in the genetically obese rat.

Authors:  C B Goodman; K F Soliman
Journal:  Experientia       Date:  1991-08-15

5.  Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.

Authors:  K M Kutty; S N Huang; K T Kean
Journal:  Experientia       Date:  1981-11-15

6.  Effect of cuprofilin on experimental atherosclerosis.

Authors:  M Vlad; E Bordas; E Caseanu; G Uza; E Creteanu; C Polinicenco
Journal:  Biol Trace Elem Res       Date:  1995-04       Impact factor: 3.738

7.  Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa.

Authors:  Piotr Duchnowicz; Anna Ziobro; Elżbieta Rapacka; Maria Koter-Michalak; Bożena Bukowska
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

8.  Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.

Authors:  Yanshuo Han; Yanan Ma; Yang Liu; Zhongyi Zhao; Shihan Zhen; Xuelian Yang; Zhiyong Xu; Deliang Wen
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-14       Impact factor: 3.168

9.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.